The DOI matches its Crossref record; 260 of the 264 references it cites were found in a registry or an index.
Neurobiology of the nicotine withdrawal syndrome
Abstract
The aversive aspects of withdrawal from chronic nicotine exposure are thought to be an important motivational factor contributing to the maintenance of the tobacco habit in human smokers. Much emphasis has been placed on delineating the underlying neurobiological mechanisms mediating different components of the nicotine withdrawal syndrome. Recent studies have shown that both central and peripheral populations of nicotinic acetylcholine receptors (nAChRs) are involved in mediating somatic signs of nicotine withdrawal as measured by the rodent nicotine abstinence scale. However, only central populations of nAChRs are involved in mediating affective aspects of nicotine withdrawal, as measured by elevations in brain-stimulation reward thresholds and conditioned place aversion. Nicotine interacts with several neurotransmitter systems, including acetylcholine, dopamine, opioid peptides, serotonin, and glutamate systems. Evidence so far suggests that these neurotransmitters play a role in nicotine dependence and withdrawal processes. The available evidence also suggests that different underlying neurochemical deficits mediate somatic and affective components of nicotine withdrawal. The aim of the present review is to discuss preclinical findings concerning the neuroanatomical and neurochemical substrates involved in these different aspects of nicotine withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dependence on tobacco smoking depends not only on the balance between the rewarding and aversive action of nicotine described above, but also on escape from the aversive consequences of nicotine withdrawal (Doherty et al. 1995;Kenny and Markou 2001).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The most common somatic symptoms include bradycardia, gastrointestinal discomfort, and increased appetite.”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“Affective symptoms primarily include depressed mood including anhedonia, dysphoria, anxiety, irritability, difficulty concentrating, and craving (Parrott 1993;Doherty et al. 1995;Kenny and Markou 2001).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The nicotine withdrawal syndrome in abstinent smokers is comprised of”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The neuroadaptations arising from chronic nicotine exposure cause widespread alterations in brain neurotransmission that promote and sustain the use of tobacco [21–24].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [22]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
NEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N. R., Feighner, J. P., Shrivastava, R. K., Carman, J. S., Sramek, J. J., Reines, S. A., Liu, G. F., Snavely, D. B., Wyatt-Knowles, E. S., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
The Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Selective activation of the mesocortical DA system by stress
Thierry, A. M., Tassin, J., BLANC, G., & Glowinski, J. (1976) · Nature · doi:10.1038/263242a0 · Cited by 1,033
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Requirement for BDNF in activity-dependent survival of cortical neurons
Ghosh, A., Carnahan, J., & Greenberg, M. E. (1994) · Science · doi:10.1126/science.7907431 · Cited by 989
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
Self-citationNicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Self-citationKlink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051622798 · Cited by 673
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
The scientific case that nicotine is addictive
Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 646
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Nicotine maintains robust self-administration in rats on a limited-access schedule
Corrigall, W. A., & Coen, K. M. (1989) · Psychopharmacology · doi:10.1007/bf00589894 · Cited by 578
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Smoking withdrawal symptoms in two weeks of abstinence
Shiffman, S. M., & Jarvik, M. E. (1976) · Psychopharmacology · doi:10.1007/bf00634151 · Cited by 542
Altar, C. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01309-7 · Cited by 535
Evidence for the involvement of TNF and NF-?B in hippocampal synaptic plasticity
Albensi, B. C., & Mattson, M. P. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2 · Cited by 527
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 521
Postcocaine anhedonia. An animal model of cocaine withdrawal.
Markou, A., & Koob, G. F. (1991) · PubMed · Cited by 505
Self-citationActivation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Role of Corticotropin-Releasing Factor in Drug Addiction
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 474
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03474.1996 · Cited by 457
Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery
Holladay, M. W., Dart, M. J., & Lynch, J. K. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970377o · Cited by 442
Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A. S., Barbosa, C. T. F., Bonfante-Cabarcas, R. A., Aracava, Y., Eisenberg, H. M., & Maelicke, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36503-6 · Cited by 437
Benwell, M. E. M., & Balfour, D. J. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09067.x · Cited by 426
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
Overview of nicotinic receptors and their roles in the central nervous system
Dani, J. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01011-8 · Cited by 421
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 417
Tobacco withdrawal in self-quitters
Hughes, J. R. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.60.5.689 · Cited by 412
Tobacco withdrawal in self-quitters.
Hughes, J. R. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.60.5.689 · Cited by 409
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Nicotinic effects on the firing pattern of midbrain dopamine neurons
GRENHOFF, J., ASTON‐JONES, G., & SVENSSON, T. H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07988.x · Cited by 399
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 381
Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex
Kawasaki, H., Adolphs, R., Kaufman, O., Damásio, H., Damásio, A. R., Granner, M. A., Bakken, H. E., Hori, T., & Howard, M. A. (2001) · Nature Neuroscience · doi:10.1038/82850 · Cited by 367
Chapter 19 The determinants of stress-induced activation of the prefrontal cortical dopamine system
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62691-6 · Cited by 364
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361
CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Persistent Behavior at High Rates Maintained by Intravenous Self-Administration of Nicotine
Goldberg, S. R., Spealman, R. D., & Goldberg, D. M. (1981) · Science · doi:10.1126/science.7291998 · Cited by 347
Decreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345
Self-citationRodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332
Alkondon, M., Pereira, E. F. R., Barbosa, C. T. F., & Albuquerque, E. X. (1997) · PubMed · Cited by 326
Taber, M. T., & Fibiger, H. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03896.1995 · Cited by 318
Weiss, F., Markou, A., Lorang, M. T., & Koob, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91327-b · Cited by 318
Self-citationPharmacological and functional diversity of neuronal nicotinic acetylcholine receptors
Deneris, E. S., Connolly, J. G., Rogers, S. W., & Duvoisin, R. M. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90486-c · Cited by 318
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress
Inglis, F., & Moghaddam, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721088.x · Cited by 310
Suaud-Chagny, M. F., Chergui, K., Chouvet, G., & Gonon, F. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90076-e · Cited by 307
Santarelli, L., Gobbi, G., Debs, P. C., Sibille, E. L., Blier, P., Hen, R., & Heath, M. J. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1912 · Cited by 303
Cigarette smoking and major depression
Covey, L. S., Glassman, A. H., & Stetner, F. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_04 · Cited by 302
Luo, S., Kulak, J. M., Cartier, G. E., Jacobsen, R. B., Yoshikami, D., Olivera, B. M., & McIntosh, J. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08571.1998 · Cited by 290
Conroy, W. G., & Berg, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4424 · Cited by 288
Schulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
Self-citationSelective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 282
Donny, E. C., Caggiula, A. R., Rowell, P. P., Gharib, M. A., Maldovan, V., Booth, S., Mielke, M. M., Hoffman, A., & McCallum, S. E. (2000) · Psychopharmacology · doi:10.1007/s002130000497 · Cited by 265
Smoking withdrawal dynamics in unaided quitters.
Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., & Baker, T. B. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.1.74 · Cited by 262
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.264.12.1546 · Cited by 251
Major depression following smoking cessation
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.263 · Cited by 250
Clonidine for smoking cessation
Gourlay, S. G., Stead, L. F., & Benowitz, N. L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000058.pub2 · Cited by 248
Nicotine self-administration in rats
Donny, E. C., Caggiula, A. R., Knopf, S., & Brown, C. (1995) · Psychopharmacology · doi:10.1007/bf02246272 · Cited by 233
The Role of Corticotropin‐Releasing Factor in Behavioural Responses to Stress
Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H. A., Miczek, K. A., & Britton, K. T. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514368.ch14 · Cited by 232
Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats
Watkins, S. S., Epping-Jordan, M. P., Koob, G. F., & Markou, A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00226-3 · Cited by 229
Self-citationAcquas, E., & Chiara, G. D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10033.x · Cited by 223
Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
Kalivas, P. W., Duffy, P., & Barrow, J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20732-7 · Cited by 215
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214
Self-citationNicotine as a reinforcer in human subjects and laboratory animals
Henningfield, J. E., & Goldberg, S. R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90405-7 · Cited by 214
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston‐Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
MALDONADO, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00061-5 · Cited by 213
Reid, M. S., Hsu, K., & Berger, S. P. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199710)27:2 · Cited by 212
Richter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4 · Cited by 210
Rewarding effects of opiates are absent in mice lacking the receptor for substance P
Murtra, P., Sheasby, A. M., Hunt, S. P., & Felipe, C. D. (2000) · Nature · doi:10.1038/35012069 · Cited by 208
Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00243-1 · Cited by 207
Fenster, C. P., Whitworth, T. L., Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04804.1999 · Cited by 204
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00373.x · Cited by 204
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200
Sudweeks, S. N., & Yakel, J. L. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00515.x · Cited by 197
Gioanni, Y., Rougeot, C., Clarke, P. B. S., Lepousé, C., Thierry, A. M., & Vidal, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00403.x · Cited by 191
Pharmacologic characterization of nicotine-induced conditioned place preference
Fudala, P. J., Teoh, K., & Iwamoto, E. T. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90384-3 · Cited by 190
Basso, A. M., Spina, M. G., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189
Sparks, J. A., & Pauly, J. R. (1999) · Psychopharmacology · doi:10.1007/s002130050818 · Cited by 188
Effects of mecamylamine on human cigarette smoking and subjective ratings
Nemeth-Coslett, R., Henningfield, J., O'Keeffe, M., & Griffiths, R. R. (1986) · Psychopharmacology · doi:10.1007/bf00178502 · Cited by 186
Chapter 10 Structure and function of neuronal nicotinic acetylcholine receptors
Lindstrom, J. M., Anand, R., Gerzanich, V., Peng, X.-D., Wang, F., & Wells, G. B. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62094-4 · Cited by 179
Fagerström, K. O., Schneider, N. G., & Lunell, E. (1993) · Psychopharmacology · doi:10.1007/bf02244941 · Cited by 176
Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor β Subunits
Harvey, S. C., & Luetje, C. W. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03798.1996 · Cited by 175
Guidance for commissioners on the cost effectiveness of smoking cessation interventions
Parrott, S., Godfrey, C., Raw, M., West, R., & McNeill, A. D. (1998) · PubMed Central · Cited by 170
Jacob, P., Yu, L., Shulgin, A. T., & Benowitz, N. L. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.5.731 · Cited by 169
Harvey, S. C., Maddox, F. N., & Luetje, C. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051953.x · Cited by 168
Risner, M. E., & Goldberg, S. R. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33473-7 · Cited by 168
Harrison, A. A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00237-2 · Cited by 167
The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Ronald Lake, J., Carter, V. A., Scott Cunningham, J., Hebert, K. M., Conrad, D. L., & Wilson, O. B. (1994) · Psychopharmacology · doi:10.1007/bf02244770 · Cited by 165
Kenny, P. J., File, S. E., & Rattray, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00246-1 · Cited by 165
Self-citationSharples, C. G. V., Kaiser, S., Soliakov, L. S., Marks, M. J., Collins, A. C., Washburn, M. S., Wright, E., Spencer, J. A., Gallagher, T., Whiteaker, P., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02783.2000 · Cited by 164
The Role of CRF in Behavioral Aspects of Stress
Heinrichs, S. C., Menzaghi, F., Pich, E. M., Britton, K. T., & Koob, G. F. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44673.x · Cited by 160
Kaiser, S., Soliakov, L. S., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031069.x · Cited by 160
Shahan, T. A., Bickel, W. K., Madden, G. J., & Badger, G. J. (1999) · Psychopharmacology · doi:10.1007/s002130051162 · Cited by 159
Nicotine self-administration in rats on a progressive ratio schedule of reinforcement
Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., Maldovan, V., Shupenko, C., & McCallum, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130051153 · Cited by 158
Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156
Presynaptic Regulation of Glutamate Release in the Ventral Tegmental Area During Morphine Withdrawal
Manzoni, O. J., & Williams, J. T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06629.1999 · Cited by 156
Nicotine self-administration in animals as a dependence model
Corrigall, W. A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 155
Markou, A., & Paterson, N. E. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073380 · Cited by 154
Self-citationGellert, V. F., & Sparber, S. B. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30826-8 · Cited by 149
Naloxone precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1993) · Psychopharmacology · doi:10.1007/bf02244930 · Cited by 147
Naloxone reduces cigarette smoking
Karras, A., & Kane, J. M. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90562-7 · Cited by 144
Grottick, A. J., Trube, G., Corrigall, W., Huwyler, J., Malherbe, P., Wyler, R., & Higgins, G. A. (2000) · PubMed · Cited by 142
Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal
Koob, G. F., Wall, T. L., & Bloom, F. E. (1989) · Psychopharmacology · doi:10.1007/bf00441954 · Cited by 142
Flores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142
Beaulieu, S., Paolo, T. D., Côté, J., & Barden, N. (2008) · Neuroendocrinology · doi:10.1159/000124701 · Cited by 140
Yeomans, J. S., & Baptista, M. A. S. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00467-4 · Cited by 139
Fu, Y., Matta, S. G., Gao, W., Brower, V. G., & Sharp, B. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39093-7 · Cited by 139
Sershen, H. W., Balla, A., Lajtha, Á., & Vizi, E. S. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00425-3 · Cited by 136
French, S. J., Humby, T., Horner, C. H., Sofroniew, M. V., & Rattray, M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00048-0 · Cited by 134
The fall and rise of neuronal α-bungarotoxin binding proteins
Clarke, P. B. S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90125-p · Cited by 133
Benwell, M. E. M., & Balfour, D. J. K. (1979) · Psychopharmacology · doi:10.1007/bf00426913 · Cited by 132
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
Diana, M., Muntoni, A. L., Pistis, M., Melis, M., & Gessa, G. L. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00488.x · Cited by 132
Alkondon, M., Pereira, E. F. R., Almeida, L. E. F., Randall, W. R., & Albuquerque, E. X. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00156-8 · Cited by 129
Nornicotine is self-administered intravenously by rats
Bardo, M. T., Green, T. A., Crooks, P. A., & Dwoskin, L. P. (1999) · Psychopharmacology · doi:10.1007/s002130051119 · Cited by 128
Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997) · Psychopharmacology · doi:10.1007/s002130050200 · Cited by 122
Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists
Shoaib, M., Benwell, M. E. M., Akbar, M., Stolerman, I. P., & Balfour, D. J. K. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14854.x · Cited by 121
Araujo, D. M., Lapchak, P. A., Collier, B., & Quirion, R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04869.x · Cited by 121
Lança, A. J., Adamson, K. L., Coen, K. M., Chow, B. L., & Corrigall, W. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00607-7 · Cited by 120
Varanda, W. A., Aracava, Y., Sherby, S. M., VanMeter, W. G., Eldefrawi, M. E., & Albuquerque, E. X. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13493-7 · Cited by 120
Hand, T. H., Koob, G. F., Stinus, L., & Moal, M. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90452-0 · Cited by 119
Crooks, P. A., & Dwoskin, L. P. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00117-2 · Cited by 118
Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers
Butschky, M. F., Bailey, D., Henningfield, J. E., & Pickworth, W. B. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00269-o · Cited by 118
Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds
Wise, R. A., & Munn, E. M. (1995) · Psychopharmacology · doi:10.1007/bf02245178 · Cited by 115
Cheeta, S., Irvine, E. E., Kenny, P. J., & File, S. E. (2001) · Psychopharmacology · doi:10.1007/s002130100681 · Cited by 113
Self-citationMarks, M. J., Farnham, D. A., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10175-4 · Cited by 112
Nisell, M., Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271290 · Cited by 112
Naltrexone Effects on Short-Term and Long-Term Smoking Cessation
Covey, L. S., Glassman, A. H., & Stetner, F. (1999) · Journal of Addictive Diseases · doi:10.1300/j069v18n01_04 · Cited by 111
Coco, M. L., Kuhn, C. M., Ely, T. D., & Kilts, C. D. (1992) · Brain Research · doi:10.1016/0006-8993(92)91079-t · Cited by 110
Spanagel, R., Almeida, O. F. X., Bartl, C., & Shippenberg, T. S. (1994) · Psychopharmacology · doi:10.1007/bf02244761 · Cited by 110
Frosch, D. L., SHOPTAW, S. J., Nahom, D., & Jarvik, M. E. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.8.1.97 · Cited by 110
Effects of nicotine on the threshold for rewarding brain stimulation in rats
Huston-Lyons, D., & Kornetsky, C. H. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90223-3 · Cited by 109
The Role of Corticotropin‐Releasing Factor in the Anxiogenic Effects of Ethanol Withdrawal
Menzaghi, F., Rassnick, S., Heinrichs, S. C., Baldwin, H. A., Pich, E. M., Weiss, F., & Koob, G. F. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb19819.x · Cited by 109
Nomikos, G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1992) · PubMed · Cited by 109
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 108
�sterlund, M. K., Halldin, C., & Hurd, Y. L. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1 · Cited by 108
Development of Major Depressive Disorder During Smoking-Cessation Treatment
Murphy, C., & Abrams, D. B. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1106 · Cited by 105
Dani, J. A., Radcliffe, K. A., & Pidoplichko, V. I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00003-0 · Cited by 103
Paterson, N. E., Myers, C., & Markou, A. (2000) · Psychopharmacology · doi:10.1007/s002130000559 · Cited by 103
Self-citationHelton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D., & Kallman, M. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00170-6 · Cited by 103
Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes
Wilkie, G., Hutson, P. H., Sullivan, J. P., & Wonnacott, S. (1996) · Neurochemical Research · doi:10.1007/bf02532425 · Cited by 103
Hildebrand, B. E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 103
Decrease of tolerance to, and physical dependence on morphine by glutamate receptor antagonists
Gonzalez, P. G., Cabello, P., Germany, A., Norris, B., & Contreras, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01099-6 · Cited by 102
Target‐Specific Glutamatergic Regulation of Dopamine Neurons in the Ventral Tegmental Area
Takahata, R., & Moghaddam, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751775.x · Cited by 101
Diazepam dependence prevented by glutamate antagonists.
Steppuhn, K. G., & Turski, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6889 · Cited by 101
Kenny, P. J., File, S. E., & Neal, M. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752409.x · Cited by 100
Self-citationNaltrexone, smoking behaviour and cigarette withdrawal
Sutherland, G., Stapleton, J., Russell, M. A., & Feyerabend, C. (1995) · Psychopharmacology · doi:10.1007/bf02245813 · Cited by 98
Nicotine abstinence in the mouse
Isola, R., Vogelsberg, V., Wemlinger, T. A., Neff, N. H., & Hadjiconstantinou, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02131-9 · Cited by 96
Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96
Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation
Schneider, N. G., Jarvik, M. E., & Forsythe, A. B. (1984) · Addictive Behaviors · doi:10.1016/0306-4603(84)90052-2 · Cited by 96
Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study
Davidson, M., Shanley, B., & Wilce, P. (1995) · Brain Research · doi:10.1016/0006-8993(94)01440-s · Cited by 94
Allosteric nicotinic receptors, human pathologies
Léna, C., & Changeux, J. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80140-x · Cited by 93
Mecamylamine-precipitated nicotine-withdrawal aversion in rats
Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00723-6 · Cited by 93
Lin, D. C.-H., Koob, G. F., & Markou, A. (1999) · Psychopharmacology · doi:10.1007/s002130051060 · Cited by 92
Self-citationSmoking-associated changes in the serotonergic systems of discrete regions of human brain
Benwell, M. E. M., Balfour, D. J. K., & ANDERSON, J. M. (1990) · Psychopharmacology · doi:10.1007/bf02245746 · Cited by 90
Lü, L. T., Liu, D., Ceng, X., & Ma, L. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01310.x · Cited by 89
Bradberry, C. W., Lory, J. D., & Roth, R. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb01987.x · Cited by 88
Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00138-6 · Cited by 87
Goldberg, S. R., & Henningfield, J. E. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90450-9 · Cited by 87
Naloxone does not affect cigarette smoking
Nemeth-Coslett, R., & Griffiths, R. R. (1986) · Psychopharmacology · doi:10.1007/bf00174355 · Cited by 86
Higgins, G. A., & Sellers, E. M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90489-8 · Cited by 85
Belluardo, N., Blum, M., Mudò, G., Andbjer, B., & Fuxé, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00323-0 · Cited by 83
Rossetti, Z. L., Melis, F., Carboni, S., & Gessa, G. L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb26016.x · Cited by 82
Helton, D. R., Modlin, D. L., Tizzano, J. P., & Rasmussen, K. (1993) · Psychopharmacology · doi:10.1007/bf02245698 · Cited by 81
Dw, S., Loring, R., Aizenman, E., & Zigmond, R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-01-00287.1991 · Cited by 78
East, S. J., Hill, M. P., & Brotchie, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00119-6 · Cited by 77
Amphetamine withdrawal: A behavioral evaluation
Kokkinidis, L., Zacharko, R. M., & Anisman, H. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90501-1 · Cited by 77
Rose, J. E., Behm, F. M., & Westman, E. C. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00465-2 · Cited by 76
Naltrexone administration affects ad libitum smoking behavior
Wewers, M. E., Dhatt, R., & Tejwani, G. A. (1998) · Psychopharmacology · doi:10.1007/s002130050756 · Cited by 76
Heinrichs, S. C., Lapsansky, J., Behan, D. P., Chan, R. K. W., Sawchenko, P. E., Lorang, M. T., LING, N. C., Vale, W., & Souza, E. B. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15475 · Cited by 76
Pandey, S. C., Roy, A., Xu, T., & Mittal, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00309.x · Cited by 75
Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice
Zarrindast, M., & Farzin, D. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00761-x · Cited by 75
Grillner, P., & Svensson, T. H. (2000) · Synapse · doi:10.1002/1098-2396(200010)38:1 · Cited by 75
Toide, K., & Arima, T. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90510-4 · Cited by 74
Irvine, E. E., Bagnalasta, M., Marcon, C., Motta, C., Tessari, M., File, S. E., & Chiamulera, C. (2000) · Psychopharmacology · doi:10.1007/s002130000586 · Cited by 73
MK801 attenuates behavioural adaptation to chronic nicotine administration in rats
Shoaib, M. C., & Stolerman, I. P. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09010.x · Cited by 72
Research works printed but not linked: 3
- Paterson, 2001, Nicotine self-administration in rats: short-term abstinence, progressive ratio schedule, and extinction with or without conditioned stimuli, Drug Alcohol Depend, 63, S120
- Ridley, 1997, The influence of nicotine on 5-HT overflow in the dorsal hippocampus of the rat, Br J Pharmacol, 112, 301P
- Wonnacott, 1993, Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses, Methods Neurosci, 12, 263
Cited by
Sorted by citations
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Cue dependency of nicotine self-administration and smoking
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00676-1 · Cited by 425
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“In the conditioned place-aversion paradigm, the animal learns to avoid the compartment in which nicotine withdrawal is experienced (Jackson et al. 2009, Kenny & Markou 2001).”
BackgroundWhat Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · SLEEP · doi:10.1093/sleep/27.6.1181 · Cited by 310
Metadata
- Authors
- Kenny, P. J., & Markou, A.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Markou, Athina
- ORCID
- Kenny, Paul J.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 70
- Issue
- 4
- Pages
- 531-549
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2020567468
- Cited by
- 310
- References
- 264
- Citations by year
- 2025: 9 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 17 · 2014: 12 · 2013: 19 · 2012: 18
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 11946, R56DA011946)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine withdrawal, nicotine dependence, nicotinic acetylcholine receptors, somatic withdrawal signs, conditioned place aversion, dopamine, opioid peptides, serotonin, glutamate, acetylcholine, neuroanatomical substrates
- MeSH terms
- Animals, Humans, Nicotine, Substance Withdrawal Syndrome, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review